BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23538642)

  • 1. Conjunctival papilloma: features and outcomes based on age at initial examination.
    Kaliki S; Arepalli S; Shields CL; Klein K; Sun H; Hysenj E; Lally SE; Shields JA
    JAMA Ophthalmol; 2013 May; 131(5):585-93. PubMed ID: 23538642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma.
    Falco LA; Gruosso PJ; Skolnick K; Bejar L
    Optometry; 2007 Apr; 78(4):162-6. PubMed ID: 17400137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis.
    Shields CL; Lally MR; Singh AD; Shields JA; Nowinski T
    Am J Ophthalmol; 1999 Sep; 128(3):362-4. PubMed ID: 10511035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-2b in the management of recurrent conjunctival papillomatosis.
    Singh M; Gautam N; Gupta A; Kaur M
    Indian J Ophthalmol; 2016 Oct; 64(10):778-780. PubMed ID: 27905345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant conjunctival nevus: clinical features and natural course in 32 cases.
    Shields CL; Regillo AC; Mellen PL; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2013 Jul; 131(7):857-63. PubMed ID: 23702735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
    Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
    Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis.
    Chang SW; Huang ZL
    Cornea; 2006 Jul; 25(6):687-90. PubMed ID: 17077661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
    Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical alpha-interferon in recurrent conjunctival papilloma.
    de Keizer RJ; de Wolff-Rouendaal D
    Acta Ophthalmol Scand; 2003 Apr; 81(2):193-6. PubMed ID: 12752062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival papilloma. A histopathologically based retrospective study.
    Sjö N; Heegaard S; Prause JU
    Acta Ophthalmol Scand; 2000 Dec; 78(6):663-6. PubMed ID: 11167228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL; Ramasubramanian A; Mellen PL; Shields JA
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.